Has Jonathan Smedley, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $105,203 in general payments to Jonathan Smedley, DPM across 610 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Smedley, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Smedley, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Smedley, DPM

Foot & Ankle Surgery · Round Rock, TXNPI 1679535553

Payments from drug & device makers

$105,203in general payments, 2019–2025

Across 610 payments — averaging $172.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Skye Orthobiologics LLC$36K
Treace Medical Concepts, Inc.$31K
Osiris Therapeutics Inc.$6K
Medline Industries LP$5K
Stryker$5K
Arthrex$4K
plus $18K from 54 others

What the payments were for

Consulting fees$22,64322%
Speaking & faculty fees$8,5008%
Travel & lodging$16,72316%
Food & beverage$17,08816%
Education$4,2044%
Gifts$460%
Other$36,00034%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Skye Orthobiologics LLC	1	$36,000
Treace Medical Concepts, Inc.	134	$30,636
Osiris Therapeutics Inc.	18	$6,487
Medline Industries LP	13	$5,416
Stryker(2 entities)	43	$4,518
Arthrex	22	$4,389
DNE LLC	2	$3,807
Smith+Nephew	77	$2,372
Mimedx Group, Inc.	8	$2,050
Medinc Of Texas	11	$1,719
Core Surgical Group	10	$1,069
AbbVie	42	$808
Amgen(2 entities)	35	$655
Paratek Pharmaceuticals, Inc.	48	$603
Arthrosurface Incorporated	3	$538
Abbott	11	$400
Trilliant Surgical LLC.	2	$351
Inari Medical, Inc.	1	$322
Orthofix Medical, Inc.	19	$281
Melinta Therapeutics, LLC	12	$276
Convatec Inc.	6	$198
Bioventus LLC	8	$191
Anika Therapeutics, Inc.	5	$157
Ossio Inc	2	$156
Zyla Life Sciences, Inc.	5	$138
KCI USA, Inc.	5	$130
Zimmer Biomet	3	$122
Bard Peripheral Vascular, Inc.	1	$118
Nevro Corp.	4	$103
Kerecis Limited	2	$90
Ortho Dermatologics, A Division Of Bausch Health US, LLC	5	$86
Tactile Systems Technology Inc	6	$80
Integra Lifesciences Corporation	4	$79
GRT US Holding, Inc.	3	$75
Medtronic	3	$68
Solventum Corporation	2	$66
Averitas Pharma Inc.	2	$58
Johnson & Johnson	2	$53
Medshape, Inc.	1	$52
Hikma Pharmaceuticals USA	3	$51
In2bones USA, LLC	1	$37
Organogenesis Inc.	5	$35
Sebela Pharmaceuticals Inc.	2	$30
Boston Scientific	1	$29
Arteriocyte Medical Systems, Inc.	2	$28
Spinesmith Holdings, LLC	1	$28
Voom Medical Devices, Inc.	1	$28
Alfasigma USA, Inc.	1	$26
Paragon 28, Inc.	1	$24
Polynovo North America LLC	1	$21
Sobi, Inc	1	$21
Acella Pharmaceuticals, LLC	1	$16
Heron Therapeutics, Inc.	1	$16
Baudax Bio Inc.	1	$15
Acera Surgical, Inc.	1	$15
Osteomed LLC	1	$14
Kowa Pharmaceuticals America, Inc.	1	$14
Nabriva Therapeutics, PLC	1	$14
Merck	1	$13
Acell, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Lapiplasty System$20,477
Grafix$6,498
GrafixPL$6,079
LAPIPLASTY SYSTEM 1$6,066
INBONE$1,652
Lapiplasty$1,478
INFINITY$1,399
Medline Unite Foot Plating System$1,124
HemiCAP MTP Resurfacing$504
Grafix PRIME$500
Grafix CORE$500
Grafix XC$500
Grafix PL PRIME$500
FLOWTRIEVER CATHETER, S$322
CT THROMBECTOMY SYSTEM KIT$322
Orthopedic Kits: UNITE Kit, Suture Anchor Instruments$315
Arsenal Sinus Support Plate$289
Proclaim IPG$257
Stravix$210
SONICANCHOR$167

How this compares

$105,203 in reported general payments places this provider in the 90th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$2,052,094

Medicare patients

569

Services billed

3,667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Colchicine	33	$2,137
Ciclopirox	57	$1,476
Gabapentin	78	$1,009
Doxycycline Monohydrate	66	$779
Meloxicam	86	$589
Allopurinol	46	$549
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	86	$500
Cephalexin	58	$259
Tramadol Hcl	44	$168
Levofloxacin	16	$105
Mupirocin	11	$81
Triamcinolone Acetonide	13	$38

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Round Rock

Richard PollakSan Antonio$6.1M
Joseph CaporussoMcAllen$6M
Mark DaltonAustin$4.1M
William McGarveyKaty$3.5M
Eugene CurryDallas$3.1M
Chad HowzeSan Antonio$2.4M
Graham HamiltonEdinburg$2.1M
Kevin VarnerHouston$1.1M
Paul KimDallas$972K
Mark RobsonAustin$957K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →